News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,492 Results
Type
Article (87579)
Company Profile (742)
Press Release (775152)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (232954)
Career Advice (4144)
Deals (39875)
Drug Delivery (148)
Drug Development (91255)
Employer Resources (205)
FDA (18296)
Job Trends (17424)
News (397230)
Policy (39877)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3005)
Academic (1)
Accelerated approval (31)
Adcomms (30)
Allergies (128)
Alliances (56878)
ALS (168)
Alzheimer's disease (1769)
Antibody-drug conjugate (ADC) (323)
Approvals (18462)
Artificial intelligence (542)
Autoimmune disease (160)
Automation (32)
Bankruptcy (403)
Best Places to Work (12575)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (457)
Bladder cancer (154)
Brain cancer (55)
Breast cancer (597)
Cancer (4637)
Cardiovascular disease (366)
Career advice (3569)
Career pathing (41)
CAR-T (297)
CDC (43)
Celiac Disease (1)
Cell therapy (783)
Cervical cancer (32)
Clinical research (76589)
Collaboration (1706)
Company closure (4)
Compensation (1044)
Complete response letters (66)
COVID-19 (2957)
CRISPR (88)
C-suite (796)
Cystic fibrosis (150)
Data (5890)
Decentralized trials (2)
Denatured (73)
Depression (129)
Diabetes (427)
Diagnostics (7092)
Digital health (32)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (263)
Drug pricing (177)
Drug shortages (22)
Duchenne muscular dystrophy (220)
Earnings (99207)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (133541)
Executive appointments (901)
FDA (21105)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1422)
Gene editing (192)
Generative AI (53)
Gene therapy (636)
GLP-1 (1001)
Government (5355)
Grass and pollen (6)
Guidances (369)
Healthcare (20818)
HIV (49)
Huntington's disease (49)
IgA nephropathy (85)
Immunology and inflammation (276)
Immuno-oncology (61)
Indications (95)
Infectious disease (3197)
Inflammatory bowel disease (204)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (226)
Interviews (816)
IPO (17893)
IRA (47)
Job creations (5200)
Job search strategy (2866)
JPM (67)
Kidney cancer (16)
Labor market (94)
Layoffs (645)
Leadership (38)
Legal (10119)
Liver cancer (92)
Longevity (14)
Lung cancer (627)
Lymphoma (362)
Machine learning (43)
Management (66)
Manufacturing (775)
MASH (162)
Medical device (14668)
Medtech (14708)
Mergers & acquisitions (22874)
Metabolic disorders (1197)
Multiple sclerosis (155)
NASH (23)
Neurodegenerative disease (336)
Neuropsychiatric disorders (88)
Neuroscience (3000)
Neurotech (1)
NextGen: Class of 2026 (7689)
Non-profit (5087)
Now hiring (66)
Obesity (577)
Opinion (328)
Ovarian cancer (153)
Pain (177)
Pancreatic cancer (196)
Parkinson's disease (278)
Partnered (36)
Patents (449)
Patient recruitment (456)
Peanut (56)
People (66539)
Pharmaceutical (135)
Pharmacy benefit managers (27)
Phase 1 (23709)
Phase 2 (33268)
Phase 3 (25038)
Pipeline (4848)
Policy (293)
Postmarket research (3547)
Preclinical (10637)
Press Release (72)
Prostate cancer (230)
Psychedelics (52)
Radiopharmaceuticals (292)
Rare diseases (858)
Real estate (7432)
Recruiting (80)
Regulatory (28613)
Reports (67)
Research institute (2704)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (71)
Schizophrenia (149)
Series A (243)
Series B (182)
Service/supplier (27)
Sickle cell disease (95)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4328)
State (2)
Stomach cancer (15)
Supply chain (89)
Tariffs (85)
The Weekly (122)
Vaccines (1056)
Venture capital (92)
Weight loss (381)
Women's health (79)
Worklife (22)
Date
Last 7 days (549)
Last 30 days (1826)
Last 365 days (28368)
2026 (2675)
2025 (28755)
2024 (35744)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1283)
Alabama (88)
Alaska (6)
Arizona (313)
Arkansas (9)
Asia (51321)
Australia (9039)
California (10645)
Canada (3004)
China (1111)
Colorado (392)
Connecticut (435)
Delaware (328)
Europe (117679)
Florida (1458)
Georgia (281)
Hawaii (4)
Idaho (66)
Illinois (798)
India (64)
Indiana (476)
Iowa (22)
Japan (377)
Kansas (133)
Kentucky (30)
Louisiana (24)
Maine (71)
Maryland (1348)
Massachusetts (7815)
Michigan (291)
Minnesota (524)
Mississippi (5)
Missouri (101)
Montana (29)
Nebraska (29)
Nevada (119)
New Hampshire (71)
New Jersey (2852)
New Mexico (31)
New York (2792)
North Carolina (1477)
North Dakota (9)
Northern California (5189)
Ohio (289)
Oklahoma (18)
Oregon (52)
Pennsylvania (2100)
Puerto Rico (23)
Rhode Island (37)
South America (1660)
South Carolina (31)
South Dakota (1)
Southern California (4084)
Tennessee (97)
Texas (1569)
United States (37394)
Utah (255)
Vermont (1)
Virginia (222)
Washington D.C. (69)
Washington State (901)
West Virginia (4)
Wisconsin (99)
Wyoming (2)
863,492 Results for "generation bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Transpire Bio’s ANDA for Generic Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
January 27, 2026
·
2 min read
Press Releases
XOMA Royalty Enters into Agreement to Acquire Generation Bio
December 16, 2025
·
10 min read
Layoffs
Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves
The layoffs will not spare Generation’s R&D team, which will initially be retained while the biotech completes its strategic review but will eventually be let go.
August 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Generation Bio Announces CEO Transition
October 22, 2025
·
3 min read
Press Releases
20n Bio and Lannacheng Announced Strategic Partnership to Advance Next-Generation Radionuclide Drug Conjugates
January 20, 2026
·
1 min read
Press Releases
Generation Bio Announces Third Quarter 2025 Financial Results
November 5, 2025
·
4 min read
Press Releases
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing
December 3, 2025
·
2 min read
Press Releases
Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
December 16, 2025
·
4 min read
Press Releases
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
January 15, 2026
·
8 min read
Press Releases
Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA
September 23, 2025
·
2 min read
1 of 86,350
Next
